Preclinical evaluation of statins as a treatment for ovarian cancer

Gynecologic Oncology

Volumn 129, Issue 2, 2013, Pages 417-424

  Robinson, Elizabeth ^a   Nandi, Mandrita ^a   Wilkinson, Laurelle L ^b   Arrowsmith, D Mark ^b   Curtis, Anthony D M ^b   Richardson, Alan ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Autophagy; Drug combination; Ovarian cancer; Statin

Indexed keywords

ATORVASTATIN; CARBOPLATIN; FARNESOL; FLUINDOSTATIN; GERANYLGERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; PACLITAXEL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CARBOPLATIN; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 84876280449     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.02.003     Document Type: Article

References (43)

1. L. Mirandola, M.J. Cannon, E. Cobos, G. Bernardini, M.R. Jenkins, W.M. Kast, and M. Chiriva-Internati Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer Int Rev Immunol 30 2011 127 137
2. J. Ledermann, P. Harter, C. Gourley, M. Friedlander, I. Vergote, G. Rustin, C. Scott, W. Meier, R. Shapira-Frommer, T. Safra, D. Matei, E. Macpherson, C. Watkins, J. Carmichael, and U. Matulonis Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer N Engl J Med 366 2012 1382 1392
3. T.J. Perren, A.M. Swart, J. Pfisterer, J.A. Ledermann, E. Pujade-Lauraine, G. Kristensen, M.S. Carey, P. Beale, A. Cervantes, C. Kurzeder, A. du Bois, J. Sehouli, R. Kimmig, A. Stahle, F. Collinson, S. Essapen, C. Gourley, A. Lortholary, F. Selle, M.R. Mirza, A. Leminen, M. Plante, D. Stark, W. Qian, M.K. Parmar, and A.M. Oza A phase 3 trial of bevacizumab in ovarian cancer N Engl J Med 365 2011 2484 2496
4. N. Berndt, A.D. Hamilton, and S.M. Sebti Targeting protein prenylation for cancer therapy Nat Rev Cancer 11 2011 775 791
5. M. Osmak Statins and cancer: current and future prospects Cancer Lett 324 2012 1 12
6. W.B. Zhong, Y.C. Liang, C.Y. Wang, T.C. Chang, and W.S. Lee Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling Endocr Relat Cancer 12 2005 615 629
7. W.B. Zhong, C.Y. Wang, T.C. Chang, and W.S. Lee Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis Endocrinology 144 2003 3852 3859
8. Y. Dai, P. Khanna, S. Chen, X.Y. Pei, P. Dent, and S. Grant Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation Blood 109 2007 4415 4423
9. H. Liu, S.L. Liang, S. Kumar, C.M. Weyman, W. Liu, and A. Zhou Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression Cancer Chemother Pharmacol 63 2009 997 1005
10. A. Hoque, H. Chen, and X.C. Xu Statin induces apoptosis and cell growth arrest in prostate cancer cells Cancer Epidemiol Biomarkers Prev 17 2008 88 94
11. Y.S. Tu, X.L. Kang, J.G. Zhou, X.F. Lv, Y.B. Tang, and Y.Y. Guan Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells Eur J Pharmacol 670 2011 356 364
12. C. Laezza, C. Bucci, M. Santillo, C.B. Bruni, and M. Bifulco Control of Rab5 and Rab7 expression by the isoprenoid pathway Biochem Biophys Res Commun 248 1998 469 472
13. S.A. Glynn, D. O'Sullivan, A.J. Eustace, M. Clynes, and N. O'Donovan The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells BMC Cancer 8 2008 9
14. H. Xiao, Q. Zhang, Y. Lin, B.S. Reddy, and C.S. Yang Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells Int J Cancer J Int Cancer 122 2008 2115 2124
15. H. Gbelcova, M. Lenicek, J. Zelenka, Z. Knejzlik, G. Dvorakova, M. Zadinova, P. Pouckova, M. Kudla, P. Balaz, T. Ruml, and L. Vitek Differences in antitumor effects of various statins on human pancreatic cancer Int J Cancer J Int Cancer 122 2008 1214 1221
16. W.S. Kim, M.M. Kim, H.J. Choi, S.S. Yoon, M.H. Lee, K. Park, C.H. Park, and W.K. Kang Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma Invest New Drugs 19 2001 81 83
17. S. Kato, S. Smalley, A. Sadarangani, K. Chen-Lin, B. Oliva, J. Branes, J. Carvajal, R. Gejman, G.I. Owen, and M. Cuello Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase J Cell Mol Med 14 2010 1180 1193
18. A. Martirosyan, J.W. Clendening, C.A. Goard, and L.Z. Penn Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance BMC Cancer 10 2010 103
19. B. Melichar, G. Ferrandina, C.F. Verschraegen, A. Loercher, J.L. Abbruzzese, and R.S. Freedman Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines Clin Cancer Res 4 1998 3069 3076
20. S. Kawata, E. Yamasaki, T. Nagase, Y. Inui, N. Ito, Y. Matsuda, M. Inada, S. Tamura, S. Noda, Y. Imai, and Y. Matsuzawa Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial Br J Cancer 84 2001 886 891
21. H. Graf, C. Jungst, G. Straub, S. Dogan, R.T. Hoffmann, T. Jakobs, M. Reiser, T. Waggershauser, T. Helmberger, A. Walter, A. Walli, D. Seidel, B. Goke, and D. Jungst Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma Digestion 78 2008 34 38
22. J.Y. Han, S.H. Lee, N.J. Yoo, L.S. Hyung, Y.J. Moon, T. Yun, H.T. Kim, and J.S. Lee A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer Clin Cancer Res 17 2011 1553 1560
23. J.Y. Han, K.Y. Lim, S.Y. Yu, T. Yun, H.T. Kim, and J.S. Lee A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive-disease small cell lung cancer Cancer 117 2011 2178 2185
24. Y. Shitara, and Y. Sugiyama Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions Pharmacol Ther 112 2006 71 105
25. F. Korodi, E. Feher, C. Szabo, I. Bodi, and A. Kovacsne-Mezei Amorphous simvastatin calcium and methods for the preparation thereof Organization WIP 2004
26. J. Witham, M.R. Valenti, A.K. De-Haven-Brandon, S. Vidot, S.A. Eccles, S.B. Kaye, and A. Richardson The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin Clin Cancer Res 13 2007 7191 7198
27. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
28. S. Vidot, J. Witham, R. Agarwal, S. Greenhough, H.S. Bamrah, G.J. Tigyi, S.B. Kaye, and A. Richardson Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells Cell Signal 22 2010 926 935
29. A. Richardson, R.K. Malik, J.D. Hildebrand, and J.T. Parsons Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation Mol Cell Biol 17 1997 6906 6914
30. A. Richardson, and T. Parsons A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK Nature 380 1996 538 540
31. A. Parikh, C. Childress, K. Deitrick, Q. Lin, D. Rukstalis, and W. Yang Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells Prostate 70 2010 971 981
32. K.M. Sane, M. Mynderse, D.T. Lalonde, I.S. Dean, J.W. Wojtkowiak, F. Fouad, R.F. Borch, J.J. Reiners Jr., R.A. Gibbs, and R.R. Mattingly A novel geranylgeranyl transferase inhibitor in combination with lovastatin inhibits proliferation and induces autophagy in STS-26 T MPNST cells J Pharmacol Exp Ther 333 2010 23 33
33. P.M. Yang, Y.L. Liu, Y.C. Lin, C.T. Shun, M.S. Wu, and C.C. Chen Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies Cancer Res 70 2010 7699 7709
34. M. Misirkic, K. Janjetovic, L. Vucicevic, G. Tovilovic, B. Ristic, U. Vilimanovich, L. Harhaji-Trajkovic, M. Sumarac-Dumanovic, D. Micic, V. Bumbasirevic, and V. Trajkovic Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin Pharmacol Res 65 2012 111 119
35. I.G. Ganley, P.M. Wong, N. Gammoh, and X. Jiang Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest Mol Cell 42 2011 731 743
36. N. Mizushima, T. Yoshimori, and B. Levine Methods in mammalian autophagy research Cell 140 2010 313 326
37. M. Schachter Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fundam Clin Pharmacol 19 2005 117 125
38. E. van der Spek, A.C. Bloem, N.W. van de Donk, L.H. Bogers, R. van der Griend, M.H. Kramer, O. de Weerdt, S. Wittebol, and H.M. Lokhorst Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma Haematologica 91 2006 542 545
39. K. Kajinami, H. Mabuchi, and Y. Saito NK-104: a novel synthetic HMG-CoA reductase inhibitor Expert Opin Investig Drugs 9 2000 2653 2661
40. A. Thibault, D. Samid, A.C. Tompkins, W.D. Figg, M.R. Cooper, R.J. Hohl, J. Trepel, B. Liang, N. Patronas, D.J. Venzon, E. Reed, and C.E. Myers Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer Clin Cancer Res 2 1996 483 491
41. T.E. Sondergaard, P.T. Pedersen, T.L. Andersen, K. Soe, T. Lund, B. Ostergaard, P. Garnero, J.M. Delaisse, and T. Plesner A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma Hematol Oncol 27 2009 17 22
42. B. Taylor-Harding, S. Orsulic, B.Y. Karlan, and A.J. Li Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells Gynecol Oncol 119 2010 549 556
43. J.W. Wojtkowiak, K.M. Sane, M. Kleinman, B.F. Sloane, J.J. Reiners Jr., and R.R. Mattingly Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin J Pharmacol Exp Ther 337 2011 65 74